Skip to content
Screener

IDEAYA Biosciences, Inc. IDYA Prepaid & Other Current

Prepaid & Other Current at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.22B-22.8%
Amgen logo
AmgenAMGN
$4.53B+32.2%
WHW
Whitehawk TherapeuticsWHWK
$2.51M+61.4%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$3.77M-42.2%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$12.49M+60.6%
Eikon Therapeutics, Inc. logo
Eikon Therapeutics, Inc.EIKN
$16.92M

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.56B+78.0%
Enterprise value$3.44B+79.5%
P/S15.3×+10.5×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206357
Line itemMarch 31, 2026December 31, 2025
Current assets
Cash and cash equivalents$157,522$112,825
Short-term marketable securities513,679526,563
Prepaid expenses and other current assets18,34621,366
Contract assets6,5605,973
Total current assets696,107666,727
Restricted cash1,2811,015
Long-term marketable securities301,713410,297

Item 1. Financial Statements (UNAUDITED).

FAQ

What is IDEAYA Biosciences, Inc.'s prepaid & other current?
IDEAYA Biosciences, Inc. (IDYA) reported prepaid & other current of $18.35M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s prepaid & other current changed year-over-year?
IDEAYA Biosciences, Inc.'s prepaid & other current increased by 19.4% year-over-year, from $15.36M to $18.35M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s prepaid & other current has grown at a 46.7% compound annual growth rate (CAGR), from $3.14M to $21.37M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about IDEAYA Biosciences, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude